DENTSPLY SIRONA Inc. $XRAY Shares Purchased by AlphaQuest LLC

Key Points

• AlphaQuest LLC significantly increased its holdings in DENTSPLY SIRONA by 1,381.8% during Q1, owning 51,523 shares valued at approximately $770,000.
• DENTSPLY SIRONA reported Q2 earnings of $0.52 EPS, surpassing estimates, despite a 4.9% revenue decline year-over-year.
• The company recently declared a quarterly dividend of $0.16, offering a 4.4% dividend yield, with a payout ratio currently at -13.50%.

AlphaQuest LLC lifted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 1,381.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 51,523 shares of the medical instruments supplier's stock after acquiring an additional 48,046 shares during the quarter. AlphaQuest LLC's holdings in DENTSPLY SIRONA were worth $770,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Quarry LP increased its stake in shares of DENTSPLY SIRONA by 25.7% in the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after acquiring an additional 780 shares during the period. Colonial Trust Co SC acquired a new stake in DENTSPLY SIRONA during the fourth quarter valued at $26,000. Covestor Ltd grew its position in DENTSPLY SIRONA by 17.5% during the first quarter. Covestor Ltd now owns 9,778 shares of the medical instruments supplier's stock valued at $146,000 after buying an additional 1,456 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new stake in DENTSPLY SIRONA during the first quarter valued at $25,000. Finally, Principal Financial Group Inc. grew its position in DENTSPLY SIRONA by 0.4% during the first quarter. Principal Financial Group Inc. now owns 457,397 shares of the medical instruments supplier's stock valued at $6,834,000 after buying an additional 1,708 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Performance

XRAY opened at $14.66 on Monday. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The company has a market cap of $2.92 billion, a price-to-earnings ratio of -3.09, a PEG ratio of 0.91 and a beta of 0.94. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $27.48. The firm's fifty day simple moving average is $15.27 and its two-hundred day simple moving average is $15.47.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million for the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company's revenue was down 4.9% compared to the same quarter last year. During the same period last year, the firm posted $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.4%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -13.50%.

Analysts Set New Price Targets

Several analysts recently commented on the stock. Stifel Nicolaus dropped their price target on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research report on Friday, August 8th. Piper Sandler dropped their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 30th. Wall Street Zen lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Wells Fargo & Company dropped their price target on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Friday, August 8th. Finally, Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Two investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.